Scandinavian Journal of Urology最新文献

Lower proportion of bladder cancer diagnosed at unscheduled hospitalization after introduction of standardized care pathways in Sweden. 在瑞典，引入标准化护理途径后，在计划外住院诊断膀胱癌的比例降低。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-10-15 DOI: 10.2340/sju.v61.46994

Fredrik Liedberg, Johannes Bobjer, Oskar Hagberg, Firas Aljabery, Truls Gårdmark, Staffan Jahnson, Tomas Jerlström, Henrik Kjölhede, Viveka Ströck, Karin Söderkvist, Anders Ullén, Lars Holmberg, Christel Häggström

{"title":"Lower proportion of bladder cancer diagnosed at unscheduled hospitalization after introduction of standardized care pathways in Sweden.","authors":"Fredrik Liedberg, Johannes Bobjer, Oskar Hagberg, Firas Aljabery, Truls Gårdmark, Staffan Jahnson, Tomas Jerlström, Henrik Kjölhede, Viveka Ströck, Karin Söderkvist, Anders Ullén, Lars Holmberg, Christel Häggström","doi":"10.2340/sju.v61.46994","DOIUrl":"https://doi.org/10.2340/sju.v61.46994","url":null,"abstract":"Objective: To investigate the probability for being diagnosed with bladder cancer in conjunction with unscheduled hospitalization before and after 2015 when standardized care pathways (SCP) for urinary tract cancer was introduced in Sweden.Material and methods: Unscheduled hospitalization was defined as in-hospital care with transurethral resection of bladder tumor without previous outpatient cystoscopy in patients with bladder cancer in BladderBaSe 2.0. Three calendar years before introduction of SCP (2011-2014) and after (2016-2019) were compared using adjusted logistic regression models to calculate the odds ratio (OR) for being diagnosed at an unscheduled hospital admission.Results: The study included 9998 and 11,647 patients diagnosed before and after the introduction of SCP, respectively. Proportions of patients diagnosed with bladder cancer in conjunction with unscheduled hospitalization was 13% before and 7% after implementation of SCP. Compared to patients diagnosed prior to introduction of SCP, patients diagnosed after had an adjusted OR for unscheduled hospitalization of 0.50 (95% confidence interval 0.46-0.55).Conclusions: Following the implementing SCP for bladder cancer, the proportion of patients diagnosed with bladder cancer during an unscheduled hospitalization in Sweden decreased, even after adjustment for potential confounders.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"241-246"},"PeriodicalIF":2.8,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149184363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Is Scandinavia ready for Aquablation? Reflections on the WATER III Trial. 斯堪的纳维亚准备好进行水消融了吗？对WATER III审判的思考。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-10-15 DOI: 10.2340/sju.v61.46999

Patrick Juliebø-Jones, Jill-Randi Harneshaug, Stephen Baug

引用次数: 0

No urethral recurrences in complete responders after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer. 肌肉浸润性膀胱癌新辅助化疗和膀胱切除术后完全缓解者无尿道复发。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-09-29 DOI: 10.2340/sju.v61.46892

Sofia Lingefelt, Viktor Nystrand, Farhood Alamdari, Johan Svensson, Amir Sherif

{"title":"No urethral recurrences in complete responders after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer.","authors":"Sofia Lingefelt, Viktor Nystrand, Farhood Alamdari, Johan Svensson, Amir Sherif","doi":"10.2340/sju.v61.46892","DOIUrl":"10.2340/sju.v61.46892","url":null,"abstract":"Objective: The Gold standard treatment for muscle-invasive bladder cancer (MIBC) in medically fit patients is neoadjuvant chemotherapy (NAC), followed by radical cystectomy (RC), usually urethra-sparing. Swedish guidelines recommend yearly urethroscopies for 5 years post-RC to detect urethral recurrences (URs). Evidence is limited regarding optimal urethral surveillance in the NAC-era for patients with MIBC. The goal was to evaluate UR-frequency across NAC-response groups: complete response (CR), i.e. pT0N0M0, and Non-CR-responses (partial response, stable disease, and progressive disease), compared with cystectomy-only controls.Materials and methods: A multicenter retrospective cohort study including 241 patients with ≥T2 disease in clinical and/or pathological staging (post-RC), urothelial or mixed urothelial histology, and undergoing urethra-sparing cystectomy between 2010 and 2024. Data were retrieved from medical records and transferred into an ethically approved database. UR was biopsy-confirmed; time to UR was analyzed using Aalen-Johansen cumulative incidence functions with the Gray's test.Results: 40% (50/123) of the NAC-patients were complete responders. Nine UR-events occurred (3.7%) in the total material. UR was observed in 3/123 (2.4%) NAC-treated and 6/118 (5.1%) in No-NAC patients (Gray's, p = 0.291). No UR occurred among complete responders to NAC (0/50) versus 3/73 in non-complete responders (Gray's, p = 0.150). Four UR-cases (44.4%) were symptom-detected (urethral bleeding).Conclusions: The total absence of urethral recurrences in NAC- and RC-treated MIBC-patients with complete responses suggests that the current Swedish recommendation of yearly urethroscopies could be reviewed since a more individualized surveillance strategy based on NAC-response may reduce unnecessary procedures.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"230-238"},"PeriodicalIF":2.8,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer. 生活方式、人体测量因素与疑似前列腺癌男性临床意义的前列腺癌诊断

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-09-08 DOI: 10.2340/sju.v61.46749

Elja Heiskanen, Sofia Kalinen, Rui Jian Chu, Mikael Högerman, Tarja Lamminen, Pekka Taimen, Ivan Jambor, Hannu Aronen, Harri Merisaari, Teija Sainio, Antti Hakanen, Otto Ettala, Kirsi Laitinen, Tommi Vasankari, Teemu Kallonen, Peter J Boström

{"title":"Lifestyle, anthropometric factors and clinically significant prostate cancer diagnosis in men with suspected prostate cancer.","authors":"Elja Heiskanen, Sofia Kalinen, Rui Jian Chu, Mikael Högerman, Tarja Lamminen, Pekka Taimen, Ivan Jambor, Hannu Aronen, Harri Merisaari, Teija Sainio, Antti Hakanen, Otto Ettala, Kirsi Laitinen, Tommi Vasankari, Teemu Kallonen, Peter J Boström","doi":"10.2340/sju.v61.46749","DOIUrl":"10.2340/sju.v61.46749","url":null,"abstract":"Objective: Lifestyle and anthropometric factors may influence prostate cancer (PCa) risk, yet evidence remains inconclusive. This study reports the associations between lifestyle and anthropometric factors and clinically significant PCa (csPCa; ISUP grade > 1) among men with clinical suspicion of PCa.Materials and methods: In this registered (NCT06116851), single-institution, prospective cohort trial, men referred for PCa diagnostics due to elevated prostate-specific antigen or abnormal digital rectal examination were included. Subjects underwent prostate diagnostics and completed detailed surveys of lifestyle, medical and family history. Physical activity was measured using a triaxial accelerometer. Anthropometric assessments included body mass index, waist circumference and magnetic resonance imaging-based body composition analyses.Results: Among 298 included men, 143 (48%) were diagnosed with csPCa. In multivariate logistic regression, higher physical activity, measured by step count (odds ratio [OR]: 0.91, 95% confidence interval [CI]: 0.82-0.99) and active smoking compared to never-smokers (OR: 0.38, 95% CI: 0.14-0.96) were inversely associated with detection of csPCa. Higher prostate-specific antigen density was associated with increased risk (OR: 1.78, 95% CI: 1.39-2.35). Body composition was not associated with csPCa. Study strengths include comprehensive data collection. Primary limitation is partial reliance on self-reported data.Conclusions: Higher measured physical activity was inversely associated with detection of csPCa in men with suspicion of PCa. Active smoking also showed an inverse association. Both findings merit further investigation.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"223-229"},"PeriodicalIF":2.8,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

All cause 90-day mortality associated with TUR-P procedure: a Swedish quality register-based study (2013-2022). 与turp程序相关的90天全因死亡率：一项基于瑞典质量登记的研究（2013-2022）。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-09-01 DOI: 10.2340/sju.v61.46751

Vachik Petrosyan, Maria Cronhjort, Johanna Albert, Truls Gårdemark, Jan Jakobsson

{"title":"All cause 90-day mortality associated with TUR-P procedure: a Swedish quality register-based study (2013-2022).","authors":"Vachik Petrosyan, Maria Cronhjort, Johanna Albert, Truls Gårdemark, Jan Jakobsson","doi":"10.2340/sju.v61.46751","DOIUrl":"10.2340/sju.v61.46751","url":null,"abstract":"Prostatic hyperplasia is among the most common urological conditions in ageing men, and transurethral resection of the prostate (TUR-P) has long been the standard surgical treatment. The perioperative mortality rate (POMR) is an important quality indicator for surgical care, yet contemporary national Swedish POMR data associated with TUR-P is lacking.Aims: The primary aim was to assess all-cause mortality up to 90-days following TUR-P in Sweden 2013-2022 and whether there was any temporal trend in POMR. The secondary aim was to assess the impact of patients' characteristics (age, ASA class and indication).Material and methods: This was an observational, register-based cohort study using data from the Swedish-Perioperative-Register (SPOR). A total of 14,052 TUR-P procedures (KED22) for benign prostatic hyperplasia or prostate cancer were included. Descriptive statistics, ANOVA, chi-square test, and multivariable-logistic regression were applied.Results: A total of 10 patients died within 30-days (0.07%) and 56 within 90-days (0.4%). No difference in annual POMR was seen over the study-period. Increasing age, higher ASA-class and cancer indication were the only independent predictors of 90-day mortality. Patients aged above 80-years had an OR of 7.9 (95% confidence interval [CI]: 2.2-42.3), ASA 4 had an OR of 12.6 (95% CI: 1.7-94.3), and cancer diagnosis had an OR of 4.4 (95% CI: 2.5-7.9) in the multivariable logistic regression.Conclusions: POMR following TUR-P in Sweden is low and numerically similar to age-adjusted background mortality in the Swedish population up to the age of 70-years. High age, ASA-class and cancer diagnosis are the strongest predictors of postoperative mortality.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"216-222"},"PeriodicalIF":2.8,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148865674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Nationwide trends in urolithiasis and stone procedures in Iceland. 冰岛尿石症和结石手术的全国趋势。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-08-31 DOI: 10.2340/sju.v61.46753

Bragi Aðalsteinsson, Edward Rumba, Jóhann Páll Ingimarsson

{"title":"Nationwide trends in urolithiasis and stone procedures in Iceland.","authors":"Bragi Aðalsteinsson, Edward Rumba, Jóhann Páll Ingimarsson","doi":"10.2340/sju.v61.46753","DOIUrl":"https://doi.org/10.2340/sju.v61.46753","url":null,"abstract":"Objective: This study aimed to assess nationwide trends in registered upper urinary tract stone disease and stone-related procedures in Iceland.Material and methods: We performed a nationwide retrospective population-based study of adults aged 18 years or older with International Classification of Diseases, 10th revision codes N20, N22 or N23 in national hospital and specialist-care data from 2010 to 2024. Crude and age-standardised incidence rates were calculated per 100,000 adults. Stone-related procedures from 2013 to 2024 were identified using Nordic Classification of Surgical Procedures codes. Temporal trends were analysed using negative binomial regression with population offsets.Results: The cohort included 9,492 adults. Registered incidence ranged from 221 to 260 per 100,000 adults and remained stable (95% confidence interval -0.6% to 0.6%; p = 0.914); age standardisation and alternative case definitions gave the same conclusion. Among patients first registered from 2013 onward, 2,432/7,766 (31%) underwent a stone-related procedure. The procedure rate increased from 124.3 to 236.5 per 100,000 adults, corresponding to a 6% annual increase. Ureteroscopy accounted for 10% of procedure registrations in 2013-2016 and 30% in 2021-2024, while shock wave lithotripsy remained the most common procedure.Conclusions: Registered upper urinary tract stone incidence remained stable, but treatment activity increased substantially. Ureteroscopy use rose rapidly, although shock wave lithotripsy remained the predominant procedure.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"210-215"},"PeriodicalIF":2.8,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148865977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Comparative analysis of surgical outcomes: open versus robot-assisted radical prostatectomy. 手术结果的比较分析：开放与机器人辅助根治性前列腺切除术。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-08-31 DOI: 10.2340/sju.v61.46750

Rikke Groth Olsen, Klaus Brasso, Andreas Røder, Lars Konge, Flemming Bjerrum, Hein Vincent Stroomberg

{"title":"Comparative analysis of surgical outcomes: open versus robot-assisted radical prostatectomy.","authors":"Rikke Groth Olsen, Klaus Brasso, Andreas Røder, Lars Konge, Flemming Bjerrum, Hein Vincent Stroomberg","doi":"10.2340/sju.v61.46750","DOIUrl":"https://doi.org/10.2340/sju.v61.46750","url":null,"abstract":"Objective: To compare surgical complications, biochemical failure, and mortality rates between open radical prostatectomy (ORP) and robot-assisted radical prostatectomy (RARP).Material and methods: All men undergoing radical prostatectomy (1995-2023) at a single academic hospital were included, and preoperative factors, surgical parameters, complications, biochemical failures, and mortality were collected. Generalized linear models and cause-specific Cox regressions stratified by surgical procedure were used. Cumulative incidences of biochemical failure were estimated with the Aalen-Johansen estimator, accounting for death as a competing risk. Analyses of surgical complications were adjusted for age and lymphadenectomy, while positive surgical margins, biochemical failure, and mortality were adjusted for preoperative PSA, pathological lymph node stage, pT category, tumor percentage, ISUP score, age, and year of surgery.Results: A total of 3,477 men were included (ORP: 1,759; RARP: 1,718). RARP was associated with reduced odds of in-hospital complications (adjusted odds ratio [aOR]: 0.28, 95% confidence interval [CI]: 0.11-0.74). RARP was associated with a reduced risk of biochemical failure compared to ORP (unadjusted hazard ratio [HR]: 0.52, 95% CI: 0.29-0.93). No other outcomes or mortality rates differed significantly.Conclusion: RARP was superior in terms of complications and non-inferior for oncological outcomes compared to ORP at our center. Although the only randomized trial yet, has not proven any significant improvement in long-term cancer control comparing the open versus robotic approach, RARP seems to have replaced ORP as the gold standard for surgical treatment of localized prostate cancer. However, the overall benefit of RARP in the surgical evolution remains elusive.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"202-209"},"PeriodicalIF":2.8,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148865767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Validation of the Stockholm3 test for prostate cancer detection in a nationwide Finnish private primary care cohort. 在芬兰全国私人初级保健队列中验证Stockholm3检测前列腺癌。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-07-20 DOI: 10.2340/sju.v61.46418

Henrikki Santti, Mika Matikainen, Kristina Hotakainen

{"title":"Validation of the Stockholm3 test for prostate cancer detection in a nationwide Finnish private primary care cohort.","authors":"Henrikki Santti, Mika Matikainen, Kristina Hotakainen","doi":"10.2340/sju.v61.46418","DOIUrl":"10.2340/sju.v61.46418","url":null,"abstract":"Objective: The Stockholm3 test combines clinical variables and biomarkers to improve the diagnosis of clinically significant prostate cancer (csPCa). We aimed to validate and compare its performance to prostate-specific antigen (PSA)-based decision-making.Material and methods: We conducted a prospective observational cohort study at a nationwide Finnish private primary care provider between July 2017 and February 2018. We included 1,379 men scheduled for PSA tests, excluding 74 men with missing PSA results or previously diagnosed prostate cancer. The clinical assessment was based on the PSA value and other clinical parameters, with clinicians unaware of the Stockholm3 result. We compared PSA-based decision-making with counterfactual Stockholm3 reflex testing.Results: Among the 1,305 men, the median age was 58 (interquartile range [IQR]: 51-64). PSA was ≥3 ng/mL in 209/1,305 (16%) men and above the age-specific reference limit in 119/1,305 (9%) men. Among men with PSA ≥1.5 ng/mL, a Stockholm3 Risk Score ≥15% would have selected 44% fewer men for further diagnostic evaluation than PSA ≥3 ng/mL (117/469 vs. 209/469). Over 6 years of registry-based follow-up, men with a Stockholm3 Risk Score ≥15% despite PSA below the age-specific reference limit represented a clinically relevant subgroup with subsequent csPCa diagnoses. The main limitation of this study was its observational design.Conclusions: The hypothetical clinical implementation of Stockholm3 reflex testing would have reduced referrals, helped standardise decision-making, and identified a different group of men for further diagnostic evaluation.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"195-201"},"PeriodicalIF":2.8,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148536752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Early intradetrusor injection of Onabotulinumtoxin A in patients with subacute spinal cord injury: The SCIBOT study. 亚急性脊髓损伤患者早期肌内注射肉毒杆菌毒素A: SCIBOT研究

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-07-07 DOI: 10.2340/sju.v61.46428

Ole Jacob Nilsen, Thomas Glott, Henriette Veiby Holm, Célia Duarte Cruz, Lars Frich

{"title":"Early intradetrusor injection of Onabotulinumtoxin A in patients with subacute spinal cord injury: The SCIBOT study.","authors":"Ole Jacob Nilsen, Thomas Glott, Henriette Veiby Holm, Célia Duarte Cruz, Lars Frich","doi":"10.2340/sju.v61.46428","DOIUrl":"10.2340/sju.v61.46428","url":null,"abstract":"Objectives: The aim of this study was to examine if early intradetrusor injections of onabotulinumtoxin A (BTX) permanently prevent the development of neurogenic detrusor overactivity (NDO) in patients with spinal cord injury (SCI).Materials and methods: Double-blinded randomised controlled trial. Patients with a sensorimotor complete subacute traumatic suprasacral SCI received intradetrusor injection of BTX or placebo at baseline (within 12 weeks after injury) and 3 months later. Urodynamic and clinical evaluation was performed at baseline, at 3 months, at 12 months and at long-term follow-up after >24 months. The primary endpoint was occurrence of NDO with contractions above 40 cmH2O. The secondary endpoints included comparisons of urodynamic parameters, as well as clean intermittent catheterisation (CIC) frequency, occurrence of urinary incontinence, and quality of life (QOL) evaluated by questionnaires.Results: Nine patients were included, with four in the placebo group and five patients in the BTX group. Two patients in the placebo group but none in the BTX group developed NDO with contractions above 40 cmH2O. Regarding the secondary outcome variables, there were lower maximum detrusor pressure, less frequent CIC, less incontinence, and better QOL in the BTX group at >24 months follow up. Although there was a trend toward better outcome measures, none of the differences were statistically significant. No adverse events were related to BTX in either group.Conclusion: Intradetrusor injection of BTX in patients with SCI during the subacute phase seems to be safe and may be beneficial, but further studies are needed.","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"61 ","pages":"188-194"},"PeriodicalIF":2.8,"publicationDate":"2026-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148397736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Letter to the Editor regarding 'Histopathological assessment practices in adult male circumcision and detection of lichen sclerosus: a retrospective single-centre study'. 致编辑的关于“成年男性包皮环切术的组织病理学评估实践和硬化苔藓的检测：一项回顾性单中心研究”的信。

IF 2.8 4区医学

Scandinavian Journal of Urology Pub Date : 2026-07-07 DOI: 10.2340/sju.v61.46472

Ahmet Murat Bayraktar

引用次数: 0